Search Results
CLL: IgHV mutational status
The impact of IGHV mutational status in treatment decisions in CLL
The prognostic value of IgHV mutational status with continuous vs time-limited therapy in CLL
What is the significance of IGHV mutations and how are they assessed?
IGHV-Mutated vs IGHV-Unmutated CLL | What’s the Difference?
Testing for IgHV and TP53 mutations to guide treatment decisions in CLL
Ibrutinib and FCR in CLL irrespective of IGHV mutation status
The origins of mutated and unmutated CLL
Case 3: An Elderly Patient With CLL, Mutated TP53 and NOTCH, Unmutated IgHV
Dr. Barr on Updated RESONATE Data in IGHV-Mutant CLL
Mutation Status Throughout the CLL Clinical Course
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL)
